AXL and melanoma: Besides its expression on myeloid cell types, AXL was also detected on NK cells and identified as a critical target of the E3 ubiquitin ligase CBL-B (casitas B-lineage lymphoma-b) in B16F10 melanoma and 4T1 mammary tumors [88].